Understanding the Cardiovascular Benefits of the Anti-Diabetes Medication SGLT2 Inhibitors

Conditions:   Heart Failure;   Type 2 Diabetes Mellitus Intervention:   Drug: Beta-hydroxy-butyrate Sponsor:   The University of Texas Health Science Center at San Antonio Not yet recruiting

Source: ClinicalTrials.gov - June 18, 2018 Category: Research Source Type: clinical trials